Adrenomedullin
    1.
    发明公开
    Adrenomedullin 失效
    肾上腺髓质素。

    公开(公告)号:EP0622458A2

    公开(公告)日:1994-11-02

    申请号:EP94302948.8

    申请日:1994-04-25

    摘要: According to the present invention, adrenomedullin which is a novel peptide having a hypotensive effect; proadrenomedullin N-terminal 20 peptide (proAM-N20) corresponding to an amino acid sequence of an N-terminus of proadrenomedullin, having a catecholamine secretion inhibitory effect; proadrenomedullin N-terminal 10-20 peptide (proAM-N(10-20)) having a Na channel inhibitory effect, and a gene encoding these peptides are provided. In addition, according to the present invention, these peptides in a sample containing adrenomdullin or proAM-N20 in an unknown amount can be quantified by using an antibody against adrenomedullin, proAM-N20, or its fragment.

    摘要翻译: 根据本发明,作为具有降血压作用的新型肽的肾上腺髓质素; 对应于具有儿茶酚胺分泌抑制作用的肾上腺髓质素的N末端氨基酸序列的前肾上腺髓质素N-末端20肽(proAM-N20) 提供具有Na通道抑制作用的前肾上腺髓质素N-末端10-20肽(proAM-N(10-20))和编码这些肽的基因。 此外,根据本发明,含有未知量的肾上腺髓质素或proAM-N20的样品中的这些肽可以通过使用针对肾上腺髓质素,proAM-N20或其片段的抗体来定量。